Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 23, 2018

Multiple Sclerosis Bladder Issues: Three Most Common Problems for Men and Women

  • Boster's MS Corner
    /
  • Urologic Symptoms
    /
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: To receive MS news and information via e-mail, Please Click here  CLICK BOX to SUBSCRIBE to our MS Learning Channel…
Boster's MS Corner

December 22, 2018

Several household chemical exposures are associated with pediatric-onset multiple sclerosis

  • MS Research Study and Reports
    /
Abstract BACKGROUND:There is limited information about the potential associations of multiple sclerosis (MS) and commonly used household chemicals. METHODS:We performed…
MS Research Study and Reports

December 22, 2018

Biomarkers in multiple sclerosis

  • MS Research Study and Reports
    /
Housley WJ1, Pitt D2, Hafler DA3. Author information Abstract Substantial effort has been made over the last six decades to identify biomarkers…
MS Research Study and Reports

December 22, 2018

Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) for Parkinson’s

  • Parkinson's info
    /
12/21/2018 First and Only FDA-Approved Inhaled Levodopa for Intermittent Treatment of OFF Episodes in People with Parkinson’s Taking Carbidopa/Levodopa  Expected…
Parkinson's info

December 20, 2018

Long Haul Paul bringing MS awareness to rural America

  • MS Educational Programs
    /
  • MS in Rural America
    /
  • Multiple Sclerosis
    /
LONG HAUL PAUL RIDING 1 MILLION MILES FOR MS AWARENESS THROUGHOUT RURAL AMERICA As  much as I enjoy riding all over…
MS Educational Programs

December 20, 2018

What prevents remyelination? New stem cell research reveals a critical culprit

  • Multiple Sclerosis
    /
  • Myelin Repair
    /
  • Stem Cell Related
    /
December 18, 2018,  University at Buffalo  Credit: CC0 Public Domain         New research on remyelination, the spontaneous regeneration…
Multiple Sclerosis

December 20, 2018

FDA Gives Green Light to Phase 2 Trial of NurOwn Stem Cell Therapy in Progressive MS Patients

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
December 19, 2018 The U.S. Food and Drug Administration (FDA) has approved BrainStorm Cell Therapeutics‘ request to open a Phase 2…
Multiple Sclerosis

December 20, 2018

#Ampyra Significantly Improves Walking Ability As Reported by MS Patients, Phase 3 Trial Shows

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Symptoms
    /
December 19, 2018 Treatment with Ampyra (dalfampridine) for 24 weeks leads to sustained and clinically meaningful improvements in walking ability as reported…
Multiple Sclerosis

December 20, 2018

Each Major Risk Factor (Like Genes, Smoking and Obesity) Can Affect Disease Course, Study Finds

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Risk factors often associated with multiple sclerosis (MS), such as genetic background, obesity and smoking, contribute independently to the disease’s variability and…
MS Research Study and Reports

December 13, 2018

Treating MS with Holistic Behaviors and Strategies: A Nutritionist’s View

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • MS Diet & Nutrition
    /
DECEMBER 7, 2018  BY ALANA KESSLER MS RD When I first met Stephanie in March, she was like any healthy…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts